CLOV Class A Clover Health Investments, Corp. - Class A Common stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 7, 2026
$4.38
· of 52w range
· above low
· to high
$1.5852w low
$5.5952w high
P/E
-5.1
EPS
$-0.44
Revenue
$1.92B
your badges
52W Range
$2–$6
Analyst Rating
BUY
Price Target
$5
P/E
-5.1
ROE
-26.2%
Net Profit Margin
-0.74%
Your badge strip is empty — pin a metric anywhere on this page.
CLOV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.38
P/E
-5.1
EPS
$-0.44
Revenue
$1.92B
ROE
-26.2%
52W Range
$2–$6
CLOV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1.92B2022-12-31 → 2025-12-31
EPS$-0.442022-12-31 → 2023-12-31
Free Cash Flow$-69M2022-12-31 → 2025-12-31
Net margin-0.74%2022-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CLOV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -5.15Y avg ≈-4.7 | ≈-4.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CLOV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -0.74%5Y avg ≈-6.0% | ≈-6.0% | 3.5% | In line | |
| EBITDA Margin (TTM) | -0.81%5Y avg ≈-6.2% | ≈-6.2% | 3.7% | In line | |
| Pretax Margin | -4.5% | · | 2.8% | Weak | |
| Net Profit Margin (TTM) | -0.74%5Y avg ≈-6.0% | ≈-6.0% | 2.9% | Top tier | |
| ROA | -15.2%5Y avg ≈-18.9% | ≈-18.9% | 3.0% | Weak | |
| ROE | -26.2%5Y avg ≈-36.3% | ≈-36.3% | 10.1% | Weak | |
| ROIC | -27.7% | · | 8.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CLOV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.55Y avg ≈1.6 | ≈1.6 | 1.7 | Low liquidity | |
| Quick Ratio | 0.45Y avg ≈0.6 | ≈0.6 | 1.3 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CLOV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 40.3%5Y avg ≈21.4% | ≈21.4% | · | · | |
| Revenue CAGR 3Y | 20.6%5Y avg ≈13.8% | ≈13.8% | · | · | |
| Revenue CAGR 5Y | 23.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CLOV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 3.45Y avg ≈3.0 | ≈3.0 | 2.4 | Top tier | |
| Revenue / Employee | ≈$2.7M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
41.1%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $0.05 | $0.03 | 47.1% |
| March 31, 2026 | $0.07 | $0.03 | 128.8% | |
| Dec. 31, 2025 | $-0.10 | $-0.11 | 5.1% | |
| Sept. 30, 2025 | $-0.05 | $-0.03 | -63.4% | |
| June 30, 2025 | $-0.02 | $-0.03 | 28.8% | |
| March 31, 2025 | $0.00 | $-0.06 | 100.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | $462M | |
| Gross Profit | · | · | $257M | $70M | $-79M | · | · | |
| SG&A Expense | $214M | $176M | $183M | $204M | $185M | $121M | $96M | |
| Operating Expenses | $2.01B | $1.42B | $1.47B | $1.38B | $2.11B | $766M | $645M | |
| Operating Income | $-86M | $-46M | $-205M | $-287M | $-637M | $-93M | $-183M | |
| Interest Expense | · | · | $7.0K | $1M | $3M | $36M | $23M | |
| Interest Income | · | · | · | · | · | $117.3K | · | |
| Pretax Income | $-86M | $-43M | $-213M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | $-364M | |
| EPS (Basic) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| EPS (Diluted) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| Shares (Basic) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| Shares (Diluted) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| EBITDA | $-87M | $-48M | $-213M | $-372M | $-637M | $-7M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $195M | $123M | $104M | $300M | $92M | $68M | |
| Short-term Investments | · | · | · | · | · | $0 | · | |
| Prepaid Expense | $18M | $13M | $14M | $18M | $15M | $8M | $0 | |
| Other Current Assets | $11M | $16M | $19M | $4M | $3M | $299.0K | · | |
| Current Assets | $308M | $343M | $428M | $625M | $753M | $190M | $0 | |
| PP&E (Net) | $6M | $5M | $5M | $6M | $2M | $2M | · | |
| PP&E (Gross) | $14M | $11M | $10M | $8M | $5M | $4M | · | |
| Accum. Depreciation | $8M | $6M | $5M | $2M | $2M | $2M | · | |
| Goodwill | · | · | $0 | $12M | $1M | $1M | · | |
| Other Non-current Assets | $24M | $13M | $14M | $16M | $10M | $9M | · | |
| Total Assets | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Accounts Payable | $36M | $35M | $37M | $32M | $28M | $31M | · | |
| Accrued Liabilities | · | · | · | · | · | $5M | $0 | |
| Current Liabilities | $209M | $214M | $261M | $432M | $372M | $164M | $118.0K | |
| Capital Leases | · | · | $3M | $4M | $5M | $6M | · | |
| Other Non-current Liabilities | $23M | $26M | $23M | $16M | $14M | $13M | · | |
| Total Liabilities | $232M | $240M | $284M | $452M | $411M | $433M | $118.0K | |
| Long-term Debt | · | · | · | · | $20M | $127M | · | |
| Total Debt | · | · | · | $0 | $20M | · | · | |
| Paid-in Capital | $2.68B | $2.58B | $2.46B | $2.32B | $2.15B | $412M | $0 | |
| Retained Earnings | $-2.29B | $-2.20B | $-2.16B | $-1.95B | $-1.62B | $-1.03B | $-17.6K | |
| Treasury Stock | $86M | $31M | $13M | $7M | $147.0K | $0 | · | |
| AOCI | $528.0K | $-2M | $-2M | $-9M | $-2M | $10.0K | · | |
| Stockholders' Equity | $309M | $341M | $286M | $357M | $540M | $-613M | $-17.6K | |
| Liabilities + Equity | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Shares Outstanding | · | · | · | · | 470,852,394 | 89,206,266 | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $-2M | $-3M | $-4M | $-2M | $200.0K | $-195.0K | $-3M | |
| Stock-based Comp | $104M | $114M | $141M | $164M | $164M | $7M | $3M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $2.0K | $2.0K | |
| Amort. of Intangibles | · | · | · | $100.0K | $700.0K | · | · | |
| Restructuring | · | $288.0K | $10M | $0 | · | · | · | |
| Other Non-cash | $-83M | $-34M | $-39M | $-28M | $142M | · | · | |
| Operating Cash Flow | $-67M | $35M | $-145M | $-204M | $-282M | $-118M | $-160M | |
| CapEx | $2M | $2M | $584.0K | $4M | $723.0K | $693.0K | $23.0K | |
| Investing Cash Flow | $4M | $565.0K | $140M | $95M | $-435M | $137M | $-182M | |
| Stock Issued | $1M | $193.0K | $1M | $0 | $284M | $0 | $0 | |
| Stock Repurchased | $18M | $2M | $0 | $0 | $147.0K | $0 | $0 | |
| Net Stock Activity | $-17M | $-2M | $-6M | $-6M | $284M | $25.0K | · | |
| Financing Cash Flow | $-53M | $-17M | $-5M | $-5M | $925M | $6M | $334M | |
| Net Change in Cash | $-116M | $18M | $-10M | $-114M | $208M | $25M | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-69M | $33M | $-116M | $-208M | $-283M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 12.7% | 0.65% | -5.4% | · | · | |
| Operating Margin | -4.4% | -3.3% | -10.2% | -10.7% | -43.3% | · | · | |
| Net Margin | -4.5% | -3.1% | -10.5% | -9.8% | -39.9% | · | · | |
| Pretax Margin | -4.5% | · | · | · | · | · | · | |
| EBITDA Margin | -4.5% | -3.5% | -10.4% | -10.7% | -43.3% | · | · | |
| ROA | -15.2% | -7.5% | -34.0% | -28.6% | -61.8% | -1.6% | · | |
| ROE | -26.2% | -12.6% | -70.2% | -91.6% | 1511.3% | -134.9% | · | |
| ROIC | -27.7% | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.6 | 1.6 | 1.4 | 2.0 | 0.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.5 | 0.2 | 0.8 | 0.8 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -29791.7 | -278.3 | -197.3 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 3.4 | 2.4 | 3.2 | 2.9 | 1.5 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.76 | $2.80 | $4.22 | $7.30 | $3.56 | · | · | |
| Cash Flow / Share | $-0.13 | $0.07 | $-0.24 | $-0.43 | $-0.68 | · | · | |
| EPS (TTM) | $-0.46 | $-0.46 | $-0.44 | $-0.71 | $-1.42 | $-1.54 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 40.3% | 8.8% | 15.0% | -25.5% | 118.8% | · | · | |
| Revenue CAGR 3Y | 20.6% | -2.3% | 23.3% | · | · | · | · | |
| Revenue CAGR 5Y | 23.4% | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | · | |
| Net Income TTM | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | · | |
| P/E | -5.1 | -6.8 | -2.2 | -1.3 | -2.6 | -10.9 | · | |
| Earnings Yield | -19.6% | -14.6% | -46.2% | -76.3% | -38.2% | -9.2% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $749M | $488M | $497M | $478M | $462M | $337M | $331M | $356M | $347M | $306M | $320M | $322M | $857M | $847M | $874M | |
| Gross Profit | · | · | · | · | · | · | · | $81M | $108M | $82M | $70M | $76M | $47M | $17M | $-12M | $13M | |
| SG&A Expense | $70M | $75M | $66M | $49M | $48M | $51M | $52M | $35M | $44M | $45M | $41M | $42M | $58M | $48M | $47M | $58M | |
| Operating Expenses | $715M | $722M | $537M | $521M | $488M | $464M | $358M | $340M | $349M | $370M | $340M | $349M | $402M | $931M | $949M | $962M | |
| Operating Income | $28M | $27M | $-49M | $-24M | $-11M | $-1M | $-21M | $-9M | $7M | $-23M | $-34M | $-29M | $-80M | $-74M | $-103M | $-87M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $0 | $7.0K | $0 | $404.0K | $390.0K | $403.0K | |
| Net Income | $28M | $27M | $-49M | $-24M | $-11M | $-1M | $-22M | $-9M | $7M | $-19M | $-41M | $-29M | $-73M | $-75M | $-104M | $-75M | |
| EPS (Basic) | $0.05 | $0.05 | · | · | $-0.02 | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | |
| EPS (Diluted) | $0.05 | $0.05 | · | · | $-0.02 | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | |
| Shares (Basic) | 524,186,885 | 522,184,385 | · | 512,743,521 | 509,043,210 | 497,056,331 | · | 490,180,103 | 487,483,087 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | |
| Shares (Diluted) | 545,447,735 | 532,501,448 | · | 512,743,521 | 509,043,210 | 497,056,331 | · | 490,180,103 | 495,179,955 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | |
| EBITDA | $28M | $27M | · | $-24M | $-11M | $-2M | · | $-9M | $7M | $-23M | $-41M | $-29M | $-74M | · | $-103M | $-87M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $78M | · | · | · | $195M | $288M | $255M | $208M | $299M | $310M | $191M | $383M | $324M | $274M | |
| Prepaid Expense | $19M | $18M | $18M | $12M | $15M | $17M | $13M | $13M | $15M | $17M | $15M | $15M | $17M | $18M | $20M | $22M | |
| Other Current Assets | $20M | $23M | $11M | $12M | $15M | $16M | $16M | $3M | $4M | $5M | $1M | $3M | $3M | $37M | $26M | $17M | |
| Current Assets | $485M | $448M | $308M | $331M | $363M | $331M | $343M | $433M | $550M | $553M | $916M | $1.13B | $1.27B | $1.46B | $1.86B | $2.49B | |
| PP&E (Net) | $7M | $7M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $3M | $2M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $8M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $25M | $25M | $24M | $27M | $16M | $14M | $13M | $11M | $10M | $10M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Total Assets | $720M | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | |
| Accounts Payable | $35M | $39M | $36M | $33M | $34M | $31M | $35M | $26M | $40M | $35M | $35M | $40M | $47M | $38M | $30M | $27M | |
| Current Liabilities | $323M | $337M | $209M | $193M | $202M | $216M | $214M | $280M | $325M | $356M | $719M | $908M | $1.11B | $1.13B | $1.60B | $2.15B | |
| Capital Leases | · | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $23M | $25M | $29M | $32M | $26M | $29M | $22M | $20M | $16M | $16M | $16M | $13M | $13M | $13M | |
| Total Liabilities | $344M | $358M | $232M | $219M | $231M | $248M | $240M | $311M | $349M | $379M | $738M | $927M | $1.13B | $1.17B | $1.64B | $2.19B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | $20M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | |
| Paid-in Capital | $2.71B | $2.70B | $2.68B | $2.66B | $2.63B | $2.60B | $2.58B | $2.55B | $2.52B | $2.49B | $2.43B | $2.40B | $2.36B | $2.28B | $2.24B | $2.20B | |
| Retained Earnings | $-2.23B | $-2.26B | $-2.29B | $-2.24B | $-2.21B | $-2.20B | $-2.20B | $-2.18B | $-2.17B | $-2.18B | $-2.09B | $-2.05B | $-2.02B | $-1.87B | $-1.80B | $-1.69B | |
| Treasury Stock | $96M | $94M | $86M | $77M | $71M | $63M | $31M | $24M | $19M | $16M | $12M | $10M | $9M | $6M | $6M | $6M | |
| AOCI | $-2M | $-672.0K | $528.0K | $471.0K | $177.0K | $-74.0K | $-2M | $852.0K | $-2M | $-3M | $-5M | $-7M | $-7M | $-11M | $-8M | $-7M | |
| Stockholders' Equity | $376M | $339M | $309M | $341M | $344M | $336M | $341M | $342M | $325M | $292M | $322M | $331M | $323M | $392M | $427M | $490M | |
| Liabilities + Equity | $720M | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 477,403,782 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-428.0K | $-441.0K | $-501.0K | $-396.0K | $-509.0K | $-437.0K | $-384.0K | $-522.0K | $-947.0K | $-671.0K | $-954.0K | $-930.0K | $-3M | $-695.0K | $-18.0K | $-17.0K | |
| Stock-based Comp | $9M | $12M | $25M | $26M | $26M | $26M | $30M | $28M | $28M | $29M | $33M | $36M | $39M | $43M | $42M | $41M | |
| Restructuring | · | · | · | · | · | · | · | $-538.0K | $473.0K | $353.0K | $1M | $5M | $2M | · | · | · | |
| Other Non-cash | · | $69M | · | · | · | $-41M | · | · | · | $17M | · | · | $114M | · | · | $-22M | |
| Operating Cash Flow | $25M | $108M | $-68M | $12M | $5M | $-16M | $-86M | $50M | $45M | $26M | $-19M | $53M | $79M | $102M | $-39M | $-57M | |
| CapEx | $682.0K | $854.0K | $597.0K | $692.0K | $569.0K | $185.0K | $315.0K | $399.0K | $397.0K | $445.0K | $243.0K | $354.0K | $251.0K | $259.0K | $173.0K | $158.0K | |
| Investing Cash Flow | $-32.0K | $-5M | $-35M | $-5M | $36M | $9M | $-1M | $-12M | $5M | $9M | $-20M | $66M | $10M | $-43M | $89M | $37M | |
| Stock Issued | · | · | $541.0K | $0 | · | · | $193.0K | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $0 | $0 | $1.0K | $0 | $18M | $0 | $0 | $-2M | $0 | $-3M | $-3M | $3M | $276.0K | $105.0K | $6M | |
| Net Stock Activity | · | $0 | · | · | · | $-18M | · | · | · | $-3M | · | · | $-3M | · | · | $-6M | |
| Financing Cash Flow | $416.0K | $-8M | $-9M | $-5M | $-8M | $-32M | $-6M | $-5M | $-3M | $-3M | $-2M | $-147.0K | $-2M | $132.0K | $458.0K | $-6M | |
| Net Change in Cash | $26M | $95M | $-112M | $1M | $33M | $-39M | $-93M | $33M | $47M | $32M | $-41M | $120M | $87M | $58M | $51M | $-26M | |
| Free Cash Flow | · | $107M | · | · | · | $-16M | · | · | · | $25M | · | · | $79M | · | · | $-57M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 24.5% | 30.3% | 23.6% | 13.1% | 14.9% | 10.5% | · | -1.4% | 1.5% | |
| Operating Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.6% | 2.0% | -6.5% | -8.6% | -5.6% | -13.8% | · | -12.1% | -10.0% | |
| Net Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.8% | 2.1% | -5.5% | -8.6% | -5.6% | -13.8% | · | -12.3% | -8.6% | |
| EBITDA Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.37% | · | -2.6% | 2.0% | -6.7% | -8.6% | -5.6% | -13.9% | · | -12.1% | -10.0% | |
| ROA | 4.3% | 4.3% | · | -4.0% | -1.7% | -0.20% | · | -1.1% | 0.77% | -1.8% | -3.2% | -1.7% | -3.5% | · | -6.3% | -4.2% | |
| ROE | 7.8% | 8.1% | · | -7.1% | -3.2% | -0.41% | · | -2.8% | 2.3% | -6.2% | -11.6% | -7.6% | -17.9% | · | -28.2% | -14.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.3 | · | 1.7 | 1.8 | 1.5 | · | 1.5 | 1.7 | 1.6 | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.2 | |
| Quick Ratio | · | · | · | · | · | · | · | 1.0 | 0.8 | 0.6 | 0.4 | 0.3 | 0.2 | · | 0.2 | 0.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4115.3 | · | · | -262.9 | -216.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.7 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 | · | 0.5 | 0.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.89 | · | |
| Revenue / Share | $1.36 | $1.41 | · | $0.97 | $0.94 | $0.93 | · | $0.68 | $0.72 | $0.71 | $1.00 | $1.07 | $1.10 | · | $1.78 | $1.85 | |
| Cash Flow / Share | · | $0.20 | · | · | · | $-0.03 | · | · | · | $0.05 | · | · | $0.17 | · | · | $-0.12 | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.68 | · | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.97 | $-0.89 | $-1.45 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.21B | · | $1.77B | $1.61B | $1.49B | · | $1.35B | $1.32B | $1.29B | $-533M | $18M | $544M | $3.01B | $2.58B | $2.15B | |
| Net Income TTM | $-18M | $-57M | · | $-58M | $-43M | $-25M | · | $-91M | $-124M | $-160M | $-227M | $-261M | $-337M | $-443M | $-402M | $-615M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.02B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $717M | · | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.8 | -2.4 | -2.4 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.4 | · | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | · | · | -57.1% | -41.6% | -40.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | · | · |
| Gross Margin % | · | · | 12.7% | · | · |
| Operating Margin % | -4.4% | -3.3% | -10.2% | · | · |
| Net Income | $-86M | $-43M | $-213M | · | · |
| Diluted EPS | · | · | $-0.44 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.6 | 1.6 | · | · |
| Quick Ratio | 0.4 | 0.9 | 0.5 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-69M | $33M | $-116M | · | · |
Institutional owners (13F) 247 filers · $880.9M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
247
Value held
$880.9M
New positions
43
Exited positions
25
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 43 (-6 vs prior Q) | 25 (+3 vs prior Q) | 84 (+28 vs prior Q) | 57 (-5 vs prior Q) | +24.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $183,960,495 | 35,106,965 | 20.88% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $94,517,344 | 18,037,661 | 10.73% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $56,844,123 | 10,846,066 | 6.45% | Shares |
| VANGUARD GROUP INC | $55,191,894 | 23,485,912 | 6.27% | Shares |
| STATE STREET CORP | $53,344,966 | 10,180,337 | 6.06% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $37,756,296 | 7,205,400 | 4.29% | Call option |
| Nuveen, LLC | $32,968,503 | 6,291,699 | 3.74% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28,931,025 | 5,521,188 | 3.28% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23,425,168 | 4,470,452 | 2.66% | Shares |
| NORTHERN TRUST CORP | $19,768,424 | 3,772,600 | 2.24% | Shares |
| PNC Financial Services Group, Inc. | $18,674,700 | 3,563,874 | 2.12% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $16,501,126 | 3,148,626 | 1.87% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $15,300,239 | 2,919,893 | 1.74% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $14,710,991 | 2,807,441 | 1.67% | Shares |
| MORGAN STANLEY | $12,022,159 | 2,294,305 | 1.36% | Shares |
| CITADEL ADVISORS LLC | $11,335,194 | 2,163,205 | 1.29% | Shares |
| D. E. Shaw & Co., Inc. | $10,299,183 | 1,965,493 | 1.17% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,456,104 | 1,804,600 | 1.07% | Put option |
| MARSHALL WACE, LLP | $8,191,111 | 1,563,189 | 0.93% | Shares |
| Invesco Ltd. | $7,004,779 | 1,336,790 | 0.80% | Shares |
| GMT Capital Corp | $6,839,248 | 1,305,200 | 0.78% | Shares |
| MACKENZIE FINANCIAL CORP | $6,798,774 | 1,297,476 | 0.77% | Shares |
| JANE STREET GROUP, LLC | $6,767,161 | 1,291,443 | 0.77% | Shares |
| Cerity Partners LLC | $6,460,322 | 1,232,886 | 0.73% | Shares |
| CAXTON ASSOCIATES LLP | $6,375,146 | 1,216,631 | 0.72% | Shares |
| Bank of New York Mellon Corp | $6,346,194 | 1,211,106 | 0.72% | Shares |
| CITADEL ADVISORS LLC | $6,236,124 | 1,190,100 | 0.71% | Put option |
| GOLDMAN SACHS GROUP INC | $6,134,688 | 1,170,742 | 0.70% | Shares |
| MILLENNIUM MANAGEMENT LLC | $5,809,698 | 1,108,721 | 0.66% | Shares |
| Point72 Asset Management, L.P. | $5,604,940 | 1,069,645 | 0.64% | Shares |
| CITADEL ADVISORS LLC | $5,373,096 | 1,025,400 | 0.61% | Call option |
| JANE STREET GROUP, LLC | $4,378,020 | 835,500 | 0.50% | Call option |
| Swiss National Bank | $4,315,140 | 823,500 | 0.49% | Shares |
| GROUP ONE TRADING LLC | $3,915,532 | 747,239 | 0.44% | Shares |
| IMC-Chicago, LLC | $3,369,477 | 643,030 | 0.38% | Shares |
| WOLVERINE TRADING, LLC | $3,096,288 | 992,400 | 0.35% | Call option |
| TUDOR INVESTMENT CORP ET AL | $2,808,116 | 535,900 | 0.32% | Call option |
| RHUMBLINE ADVISERS | $2,726,870 | 520,397 | 0.31% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $2,558,074 | 488,182 | 0.29% | Shares |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2,528,269 | 482,494 | 0.29% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2,421,577 | 462,133 | 0.27% | Shares |
| DEUTSCHE BANK AG\ | $2,309,776 | 440,797 | 0.26% | Shares |
| UBS Group AG | $2,145,519 | 409,450 | 0.24% | Shares |
| WELLS FARGO & COMPANY/MN | $2,070,099 | 395,057 | 0.24% | Shares |
| Legal & General Group Plc | $2,032,108 | 387,807 | 0.23% | Shares |
| ALGERT GLOBAL LLC | $1,965,419 | 375,080 | 0.22% | Shares |
| PEAK6 LLC | $1,954,520 | 373,000 | 0.22% | Call option |
| BANK OF AMERICA CORP /DE/ | $1,860,273 | 355,014 | 0.21% | Shares |
| JPMORGAN CHASE & CO | $1,673,457 | 296,369 | 0.19% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $1,607,129 | 306,704 | 0.18% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ChaChaCha SPAC C LLC, Chamath Palihapitiya | Oct. 4, 2022 | · | Initial filing | · | SEC |
| SCH Sponsor III LLC, ChaChaCha SPAC C LLC, Chamath Palihapitiya, Ian Osborne ×2 filings | Jan. 14, 2022 | · | Initial filing | · | SEC |
| Vivek Garipalli | Jan. 19, 2021 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 29 insiders · 15 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Andrew Toy | Chief Executive Officer | Oct. 1, 2026 S | 9,140,510 | 0 | 4 | $-3,704,610 |
| Jamie L. Reynoso | CEO, Medicare Advantage | Sept. 17, 2026 S | 2,803,446 | 0 | 16 | $-456,213 |
| Conrad Wai | CEO, Counterpart Health | Sept. 15, 2026 S | 1,170,056 | 0 | 3 | $-2,408,584 |
| Brady Patrick Priest | CEO of Clover Care Services | May 13, 2026 S | 2,040,222 | 0 | 2 | $-724,847 |
| Aric R Sharp | CEO of Value Based Care | Aug. 9, 2024 F | 2,100,665 | 0 | 0 | $0 |
| Joseph Clay Thornton | Interim CFO | Aug. 17, 2026 S | 1,249,526 | 0 | 2 | $-99,654 |
| Peter J. Kuipers | Chief Financial Officer | Jan. 29, 2026 F | 5,758,353 | 0 | 0 | $0 |
| Scott J. Leffler | Chief Financial Officer | Jan. 25, 2024 F | 4,857,303 | 0 | 0 | $0 |
| Joseph F. Wagner | Chief Financial Officer | Aug. 9, 2021 C | 25,000 | 0 | 0 | $0 |
| Joseph Frank Oldakowski | VP OF FINANCE AND CONTROLLER | Sept. 16, 2026 S | 275,897 | 0 | 3 | $-176,725 |
| Karen Soares | Chief Legal Officer | Sept. 15, 2026 S | 1,607,371 | 0 | 4 | $-336,594 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | Chief Technology Officer | Oct. 31, 2023 A | 3,093,225 | 0 | 0 | $0 |
| Joseph Richards Martin | General Counsel | June 14, 2023 F | 2,718,857 | 0 | 0 | $0 |
| Prabhdeep Singh | Chief Growth Officer | Sept. 16, 2022 A | 872,821 | 0 | 0 | $0 |
| Gia Lee | General Counsel & Secretary | Jan. 7, 2021 A | · | 0 | 0 | $0 |
| Brian James Miller | Director | Sept. 30, 2026 A | 12,481 | 0 | 0 | $0 |
| Robert G Torricelli | Director | Sept. 30, 2026 A | 186,897 | 0 | 0 | $0 |
| Carladenise Armbrister Edwards | Director | May 18, 2026 S | 285,432 | 0 | 1 | $-229,687 |
| Vivek Garipalli | Director | Jan. 7, 2026 M | 1,856,247 | 0 | 0 | $0 |
| Anna U Loengard | Director | Jan. 6, 2026 A | 527,456 | 0 | 0 | $0 |
| Demetrios L. Kouzoukas | Director | Jan. 6, 2026 A | 605,980 | 0 | 0 | $0 |
| William G Robinson Jr | Director | Jan. 6, 2026 A | 597,987 | 0 | 0 | $0 |
| Thomas L Tran | Director | Jan. 6, 2026 A | 180,029 | 0 | 0 | $0 |
| Chelsea Clinton | Director | Jan. 6, 2025 A | 602,814 | 0 | 0 | $0 |
| Lee Shapiro | Director | Jan. 6, 2025 A | 598,622 | 0 | 0 | $0 |
| Nathaniel S. Turner | Director | Jan. 7, 2021 A | · | 0 | 0 | $0 |
| Ian Osborne | 10% owner | Jan. 7, 2021 M | 25,500,000 | 0 | 0 | $0 |
| James Ryans | · | Jan. 7, 2021 M | 100,000 | 0 | 0 | $0 |
| Jacqueline D Reses | · | Jan. 7, 2021 M | 300,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 25 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 0.88% | 601,135 SH | Oct. 2, 2026 | Daily |
| IHF · iShares Trust | 0.28% | 778,656 SH | Sept. 11, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.25% | 158,213 SH | Oct. 2, 2026 | Daily |
| IWO · iShares Trust | 0.13% | 3,960,261 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.13% | 451,034 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.10% | 636,652 SH | Oct. 2, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.07% | 2,420,762 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.07% | 10,919,497 SH | Sept. 11, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 109,827 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.06% | 201,395 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.03% | 1,226,414 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 193,636 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 4,645,340 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.02% | 23,436 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 502,203 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 615,231 SH | Sept. 11, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 23,911 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 109,551 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 228,838 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 21,592 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 486 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 12,982,885 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 34,580 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 19,297 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 91,976 SH | Sept. 11, 2026 | Daily |
CLOV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$5.25
+19.9%
2 20.0%
Strong Buy
4 40.0%
Buy
4 40.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-09-30Mean target $5.38 +22.7%
← Below all targets
Current price $4.38
Low$5.00
Mean$5.38
High$6.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 7, 2026